More than a month after the US Food and Drug Administration first reported shortages, major generics manufacturers are continuing to struggle to meet an upsurge in demand for liquid-dose amoxicillin, one of the most commonly prescribed pediatric antibiotics.
The US Food and Drug Administration’s database of medicine shortages lists Aurobindo, Hikma, Sandoz and Teva, which are currently experiencing...




